BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27488532)

  • 1. The Genomic Landscape of Pancreatic and Periampullary Adenocarcinoma.
    Sandhu V; Wedge DC; Bowitz Lothe IM; Labori KJ; Dentro SC; Buanes T; Skrede ML; Dalsgaard AM; Munthe E; Myklebost O; Lingjærde OC; Børresen-Dale AL; Ikdahl T; Van Loo P; Nord S; Kure EH
    Cancer Res; 2016 Sep; 76(17):5092-102. PubMed ID: 27488532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent MET copy number gain and KRAS mutation is a poor prognostic factor in pancreatobiliary subtype ampullary cancers.
    Kwon MJ; Kim JW; Jeon JY; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Min KW; Choe JY; Lee HK
    Pathol Res Pract; 2017 Apr; 213(4):381-388. PubMed ID: 28214200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low incidence of KRAS, BRAF, and PIK3CA mutations in adenocarcinomas of the ampulla of Vater and their prognostic value.
    Kwon MJ; Kim JW; Jung JP; Cho JW; Nam ES; Cho SJ; Kim JS; Park HR; Min SK; Seo J; Min KW; Kim DH; Jeon JY
    Hum Pathol; 2016 Apr; 50():90-100. PubMed ID: 26997442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling identifies markers of ampullary adenocarcinoma.
    Van Heek NT; Maitra A; Koopmann J; Fedarko N; Jain A; Rahman A; Iacobuzio-Donahue CA; Adsay V; Ashfaq R; Yeo CJ; Cameron JL; Offerhaus JA; Hruban RH; Berg KD; Goggins M
    Cancer Biol Ther; 2004 Jul; 3(7):651-6. PubMed ID: 15136764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular signatures of mRNAs and miRNAs as prognostic biomarkers in pancreatobiliary and intestinal types of periampullary adenocarcinomas.
    Sandhu V; Bowitz Lothe IM; Labori KJ; Lingjærde OC; Buanes T; Dalsgaard AM; Skrede ML; Hamfjord J; Haaland T; Eide TJ; Børresen-Dale AL; Ikdahl T; Kure EH
    Mol Oncol; 2015 Apr; 9(4):758-71. PubMed ID: 25579086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.
    O'Connor JK; Sause WT; Hazard LJ; Belnap LP; Noyes RD
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1060-6. PubMed ID: 15978737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel hotspot and rare somatic mutation p.A138V, at TP53 is associated with poor survival of pancreatic ductal and periampullary adenocarcinoma patients.
    Saha G; Singh R; Mandal A; Das S; Chattopadhyay E; Panja P; Roy P; DeSarkar N; Gulati S; Ghatak S; Ghosh S; Banerjee S; Roy B; Ghosh S; Chaudhuri D; Arora N; Biswas NK; Sikdar N
    Mol Med; 2020 Jun; 26(1):59. PubMed ID: 32552660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent disease after microscopically radical (R0) resection of periampullary adenocarcinoma in patients without adjuvant therapy.
    de Castro SM; Kuhlmann KF; van Heek NT; Busch OR; Offerhaus GJ; van Gulik TM; Obertop H; Gouma DJ
    J Gastrointest Surg; 2004 Nov; 8(7):775-84; discussion 784. PubMed ID: 15531230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct chromosomal aberrations of ampulla of Vater and pancreatic head cancers detected by laser capture microdissection and comparative genomic hybridization.
    Chang MC; Chang YT; Tien YW; Sun CT; Wu MS; Lin JT
    Oncol Rep; 2005 Oct; 14(4):867-72. PubMed ID: 16142344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Pancreatic Fistula on Recurrence and Long-Term Prognosis of Periampullary Adenocarcinomas after Pancreaticoduodenectomy.
    Serrano PE; Kim D; Kim PT; Greig PD; Moulton CA; Gallinger S; Wei AC; Cleary SP
    Am Surg; 2016 Dec; 82(12):1187-1195. PubMed ID: 28234183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 accumulation confers prognostic information in resectable adenocarcinomas with ductal but not with intestinal differentiation in the pancreatic head.
    Bergan A; Gladhaug IP; Schjolberg A; Bergan AB; Clausen OP
    Int J Oncol; 2000 Nov; 17(5):921-6. PubMed ID: 11029493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
    Westgaard A; Pomianowska E; Clausen OP; Gladhaug IP
    Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-pancreatic periampullary adenocarcinomas: an explanation for favorable prognosis.
    Katz MH; Bouvet M; Al-Refaie W; Gilpin EA; Moossa AR
    Hepatogastroenterology; 2004; 51(57):842-6. PubMed ID: 15143931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preservation of the pylorus in duodenocephalopancreatectomy in pancreatic and periampullary carcinoma].
    Mosca F; Giulianotti PC; Balestracci T; Boggi U; Giardino D; Di Candio G; Rossi G; Fornaciari G
    Chir Ital; 1994; 46(2):59-67. PubMed ID: 7954986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of prognosis-associated factors in pancreatic head and peri-ampullary cancer].
    Roder JD; Siewert JR
    Chirurg; 1992 May; 63(5):410-5. PubMed ID: 1376655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
    Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
    Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and comparative outcomes of periampullary cancer: A population-based analysis demonstrating improved outcomes and increased use of adjuvant therapy from 2004 to 2012.
    Hester CA; Dogeas E; Augustine MM; Mansour JC; Polanco PM; Porembka MR; Wang SC; Zeh HJ; Yopp AC
    J Surg Oncol; 2019 Mar; 119(3):303-317. PubMed ID: 30561818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygous deletion of the MTAP gene in invasive adenocarcinoma of the pancreas and in periampullary cancer: a potential new target for therapy.
    Hustinx SR; Hruban RH; Leoni LM; Iacobuzio-Donahue C; Cameron JL; Yeo CJ; Brown PN; Argani P; Ashfaq R; Fukushima N; Goggins M; Kern SE; Maitra A
    Cancer Biol Ther; 2005 Jan; 4(1):83-6. PubMed ID: 15662124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal and pancreatobiliary differentiation in periampullary carcinoma: the role of immunohistochemistry.
    Kumari N; Prabha K; Singh RK; Baitha DK; Krishnani N
    Hum Pathol; 2013 Oct; 44(10):2213-9. PubMed ID: 23834763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of pancreaticoduodenectomy in the treatment of periampullary tumors].
    Norero E; Viñuela E; Báez S; Martínez C; Reyes J; Kusanovic R; Sanhueza M; Aguayo G; Calvo A; Mege RM; Caracci M; Díaz A
    Rev Med Chil; 2011 Aug; 139(8):1015-24. PubMed ID: 22215331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.